Supporting 0 to 1 (Idea to NewCo)

Biotech Startups

 

Viva Ventures Biotech Fund

 

We are a corporate VC fund that focuses on investments in global first-in-class, discovery-stage biotech startups with significant growth potential. Viva Ventures is one of very few biotech VCs that have extensive expertise and industry know-how for early stage investments.

Supporting Biotech Startups since 2008

Viva Ventures Biotech Fund is backed by the founders of top biotech startups and chief scientists of incubator centers, giving us access to the top startups around the world including Viva Biotech incubators in China, Boston CIC, and Hong Kong Science Park. Viva Ventures Fund I is purely financed by Dr.  Mao Jun.

Our Strategies

 

Our Investment Thesis:

Early Stage = Achieve Superior Return

How to Achieve Higher Success Rate:

Genetic Linkage, Biomarkers and SBDD

Phase 2a/2 Clinical Success Rates

Impact of Structure-Based Drug Design (SBDD)

*Source: Nature Review, Volume 13, June 2014

  • Projects that showed greater confidence in target validation through human genetic target linkage to the disease were less likely to fail owing to a lack of efficacy

  • 73% of projects with some genetic linkage of the target to the disease were active or successful in Phase II compared with 43% of projects without such data, also that of projects with biomarkers could exceed 80%

Deal Flow Funnel

Global Ecosystem for Deal Sourcing and Exiting

Global Pharmas and Biotech Companies Include:

Our Track Record

 

Viva Ventures Fund I Track Record 

2 Years    DPI: 42%    TVPI: 15.5X    NIRR 80%

Disclaimer: This page is intended for qualified investors and no one should construe the contents of this page as legal, tax, investment, financial, or other advice.

Diversified Portfolio Overview

* Including all the projects invested by Fund I and Fund II

Our Team

 

Fund Management

Jun Mao-低分辨率.jpg

Jun Mao, PhD

Founder and Chairwoman

 

  • Founding Director of Viva Biotech, a HK listed company with 100X+ investment return

  • Active biotech investor since 2008, invested 13 biotech and drug discovery startups

  • Working at top tier IB in City of London 1996-2009 after Ph.D. in Theoretical Physics (UK)

Lou Tartaglia PhD.png

Lou Tartaglia, PhD

Partner

  • Former Partner at Third Rock Ventures, CEO of Solstice Biologics, General Manager at GeneLogic, and Vice President of Metabolic Diseases at Millennium Pharmaceuticals 

JMCR_LOGO_4_edited.jpg

About 30 Top GP Advisory Partners

  • 20+ years top biotech VC and/or drug discovery businesses   

Our partners have extensive experience & track record:

GP Advisory Partners’ Role

  • Deal Sourcing

  • Deal Evaluation

  • DD & Negotiation

  • Exit Support

GP Advisory Partners’ Profile

  • Inventors of listed/ clinical stage drugs

  • 20+ years of experience in drug discovery

  • Diversified expertise

  • Carry sharing

  • None compete

  • Right of first to know

Contact Us

 

Send us a message

arrow&v

USEFUL LINKS

 

     JMCR Partners

 

     Sprout BioVentures

 

     Viva Biotech 

SITE NAVIGATION

 

     Home

 

     About Us

 

     Strategy

 

     Track Record

     Our Team

 

     Contact Us

  • Black Facebook Icon
  • Black LinkedIn Icon

This website is for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation for any security; nor does it constitute an offer to provide investment advisory or other services by Viva Ventures Biotech Fund or any of our affiliates. Nothing contained on the website constitutes investment advice or offers any opinion with respect to the suitability of any security, and the views expressed on this website should not be taken as advice to buy, sell, or hold any security or as an endorsement of any security or company. In preparing the information contained in this website, Viva Ventures Biotech has not taken into account the investment needs, objectives, and financial circumstances of any particular investor, and investments and companies referenced may not be suitable for all investors. Any views expressed on this website by Viva Ventures biotech were prepared based upon information, believed to be reliable, available to it at the time such views were written. Viva Ventures Biotech makes no guarantees as to their accuracy or completeness. All information is subject to change and may quickly become unreliable for various reasons, including changes in market conditions or economic circumstances. By accessing this website, the reader agrees that he/she not copy, reproduce, republish, upload, post, transmit, alter, or distribute in any way material from this website in any manner inconsistent with the purposes for which it is offered without the prior written consent of Viva Ventures Biotech.